AlphAIalphai — Financial news for AI agents
StockNASDAQ · US · USDHealthcare · Biotechnology

$YARW

Yarrow Bioscience, Inc.

Price · $YARWvia TradingView
AI sentiment · 7d1 articles
AUG 22net (bullish − bearish)AUG 28
Bullish
1
Neutral
0
Bearish
0
Insider · 30dAll trades →

No SEC Form 4 filings for $YARW in the last 30 days.

See all $YARW insider activity →
Top stories · $YARWMore →
AUG 24·rttnews.comMed

Biotech Gainers: PMI Revenue Growth, SDOT Earnings Surge, CAPR FDA Update, GRI Data Drive Gains

Picard Medical (PMI) rose 40% after reporting Q2 revenue growth of 39% to $3.0M. Sadot Group (SDOT) surged 100% despite zero revenue, with net income up to $35.2M. Capricor Therapeutics (CAPR) gained 11% after FDA extended review for deramiocel. GRI Bio (GRI) climbed 10% with Phase 2a data selected for ERS 2026. Biomea Fusion (BMEA) rose 14% after completing Phase 2 diabetes trial enrollment. Yarrow Bioscience (YARW) advanced 12% with Graves' disease trial updates.

AUG 4·rttnews.com

Biotech Stocks At 52-Week Highs - ANGO, ANIK, ELOX, YARW, PLSE

Biotech shares hit 52-week highs on Aug. 3-4, 2026, led by catalysts including upcoming quarterly reports and clinical-trial updates. AngioDynamics (ANGO) reached $15.41, citing FDA clearance for its RELIEF study and FY2026 net sales of $320.2 million. Anika (ANIK) hit $21.11 after Q2 revenue rose to $32.6 million. Pulse (PLSE) rose to $38.29 ahead of Aug. 6 results; Eloxx (ELOX) and Yarrow (YARW) also reached highs.

YARW sentiment & insider activity

Over the past 7 days, alphai's AI scored 1 news story mentioning YARW (Yarrow Bioscience, Inc.). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.

Recent YARW coverage spans earnings and sector analysis.

What's driving YARW

alphai scores every news story that mentions YARW with an AI model for sentiment and relevance, and aggregates insider trades from Yarrow Bioscience, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $YARW

Score
AUG 24$PMIMedrttnews.com

Biotech Gainers: PMI Revenue Growth, SDOT Earnings Surge, CAPR FDA Update, GRI Data Drive Gains

Picard Medical (PMI) rose 40% after reporting Q2 revenue growth of 39% to $3.0M. Sadot Group (SDOT) surged 100% despite zero revenue, with net income up to $35.2M. Capricor Therapeutics (CAPR) gained 11% after FDA extended review for deramiocel. GRI Bio (GRI) climbed 10% with Phase 2a data selected for ERS 2026. Biomea Fusion (BMEA) rose 14% after completing Phase 2 diabetes trial enrollment. Yarrow Bioscience (YARW) advanced 12% with Graves' disease trial updates.

3 min read
AUG 4$ANGOLowrttnews.com

Biotech Stocks At 52-Week Highs - ANGO, ANIK, ELOX, YARW, PLSE

Biotech shares hit 52-week highs on Aug. 3-4, 2026, led by catalysts including upcoming quarterly reports and clinical-trial updates. AngioDynamics (ANGO) reached $15.41, citing FDA clearance for its RELIEF study and FY2026 net sales of $320.2 million. Anika (ANIK) hit $21.11 after Q2 revenue rose to $32.6 million. Pulse (PLSE) rose to $38.29 ahead of Aug. 6 results; Eloxx (ELOX) and Yarrow (YARW) also reached highs.

7 min read

Related tickers

More in Biotechnology